tetano
Editor, Senior Moderator
J Infect Chemother
. 2022 Dec 13;S1341-321X(22)00326-9.
doi: 10.1016/j.jiac.2022.12.003. Online ahead of print.
Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities
Daiki Tomidokoro[SUP] 1 [/SUP], Yusuke Asai[SUP] 2 [/SUP], Kayoko Hayakawa[SUP] 3 [/SUP], Satoshi Kutsuna[SUP] 4 [/SUP], Mari Terada[SUP] 5 [/SUP], Wataru Sugiura[SUP] 6 [/SUP], Norio Ohmagari[SUP] 3 [/SUP], Yukio Hiroi[SUP] 7 [/SUP]
Affiliations
Abstract
Aim: To compare the characteristics and clinical course of patients with coronavirus disease (COVID-19) according to the healthcare level of the admitted hospital, to provide an insight into determining the appropriate level of care for each patient.
Methods: This retrospective, observational study utilized data from the COVID-19 Registry Japan (COVIREGI-JP), the largest Japanese registry of hospitalized patients with COVID-19. Datasets were obtained from reports filed as of May 31, 2022.
Results: A total of 59,707 patients (2004 in the primary care group, 41,420 in the secondary care group, and 16,283 in the tertiary care group) from 585 facilities were included in the analysis. Patients with established risk factors for severe disease, such as old age and the presence of comorbidities, were treated at higher care facilities and had poorer initial conditions and in-hospital clinical course, as well as higher mortality. Analysis of the fatality rates for each complication suggested that patients with complications requiring procedures (e.g. pleural effusions, myocardial ischemia, and arrhythmia) may have better survival rates in facilities with specialist availability. The number of deaths and severe COVID-19 cases in this study were notably less than those reported overseas.
Conclusion: Our results showed that more difficult COVID-19 cases with poor outcomes were treated at higher care level facilities in Japan. Attending to possible complications may be useful for selecting an appropriate treatment hospital. Healthcare providers need to maintain a broad perspective on the distribution of medical resources.
Keywords: COVID-19; Healthcare policy; Japan; Level of care; Medical resources; Registry.
. 2022 Dec 13;S1341-321X(22)00326-9.
doi: 10.1016/j.jiac.2022.12.003. Online ahead of print.
Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities
Daiki Tomidokoro[SUP] 1 [/SUP], Yusuke Asai[SUP] 2 [/SUP], Kayoko Hayakawa[SUP] 3 [/SUP], Satoshi Kutsuna[SUP] 4 [/SUP], Mari Terada[SUP] 5 [/SUP], Wataru Sugiura[SUP] 6 [/SUP], Norio Ohmagari[SUP] 3 [/SUP], Yukio Hiroi[SUP] 7 [/SUP]
Affiliations
- PMID: 36526254
- DOI: 10.1016/j.jiac.2022.12.003
Abstract
Aim: To compare the characteristics and clinical course of patients with coronavirus disease (COVID-19) according to the healthcare level of the admitted hospital, to provide an insight into determining the appropriate level of care for each patient.
Methods: This retrospective, observational study utilized data from the COVID-19 Registry Japan (COVIREGI-JP), the largest Japanese registry of hospitalized patients with COVID-19. Datasets were obtained from reports filed as of May 31, 2022.
Results: A total of 59,707 patients (2004 in the primary care group, 41,420 in the secondary care group, and 16,283 in the tertiary care group) from 585 facilities were included in the analysis. Patients with established risk factors for severe disease, such as old age and the presence of comorbidities, were treated at higher care facilities and had poorer initial conditions and in-hospital clinical course, as well as higher mortality. Analysis of the fatality rates for each complication suggested that patients with complications requiring procedures (e.g. pleural effusions, myocardial ischemia, and arrhythmia) may have better survival rates in facilities with specialist availability. The number of deaths and severe COVID-19 cases in this study were notably less than those reported overseas.
Conclusion: Our results showed that more difficult COVID-19 cases with poor outcomes were treated at higher care level facilities in Japan. Attending to possible complications may be useful for selecting an appropriate treatment hospital. Healthcare providers need to maintain a broad perspective on the distribution of medical resources.
Keywords: COVID-19; Healthcare policy; Japan; Level of care; Medical resources; Registry.